Is Barrett's esophagus the precursor of most adenocarcinomas of the esophagus and cardia? A biochemical study

J C Mendes de Almeida, P Chaves, A D Pereira, N K Altorki, J C Mendes de Almeida, P Chaves, A D Pereira, N K Altorki

Abstract

Objective: To obtain biochemical evidence that Barrett's esophagus (BE) is the precursor of most adenocarcinomas (Adc) of the esophagus and cardia.

Summary background data: Based on morphologic data, BE was previously proposed as the precursor of most Adc of the esophagus. This hypothesis would receive strong support if biochemical evidence were found to demonstrate a pattern common to BE and Adc of the esophagus and cardia.

Methods: We studied the presence of intestinal-type proteins sucrase-isomaltase (SI) and crypt Cell Antigen (CCAg) in BE, Barrett's Adc, and esophageal-cardial Adc without BE. In each case specimens were collected from normal esophagus, stomach, tumor, and BE mucosa when present. To study related conditions, five specimens of peptic esophagitis and of squamous cell carcinoma were also analyzed. An indirect immunofluorescence technique was employed and sections were analyzed with laser confocal microscopy imaging.

Results: Most Barrett's mucosa specimens stained positively for SI (93%) and CCAg (89%). These proteins were detected in BE independently of the type of metaplasia, the coexistence of dysplasia, or the presence of associated Adc. SI and CCAg were present in 25 (96%) and 24 (92%) of the cases of Adc respectively. No statistical difference was detected in SI and CCAg expression between Adc samples with and without BE, between BE and Adc samples with or without BE, and between tumors located in the esophagus versus the cardia. No staining for these proteins was detected in stomach or esophageal mucosa, in submucosal glands of the esophagus, in peptic esophagitis or squamous cell carcinoma.

Conclusion: These data show that BE and Adc of the esophagus and cardia have a similar phenotype and support the hypothesis that most of these tumors probably originate from preexisting BE.

References

    1. Int J Cancer. 1984 Nov 15;34(5):591-8
    1. Ann Surg. 1983 Oct;198(4):554-65
    1. Dev Biol. 1985 Oct;111(2):267-79
    1. Ann Surg. 1986 Feb;203(2):188-95
    1. Proc Natl Acad Sci U S A. 1986 Mar;83(6):1723-7
    1. J Natl Cancer Inst. 1986 Apr;76(4):571-85
    1. J Natl Cancer Inst. 1986 Aug;77(2):405-15
    1. Br J Surg. 1987 Jun;74(6):481-2
    1. Adv Surg. 1988;21:127-55
    1. Hum Pathol. 1988 Feb;19(2):166-78
    1. Virchows Arch A Pathol Anat Histopathol. 1988;413(4):303-12
    1. Cell. 1990 Jun 1;61(5):759-67
    1. Surgery. 1990 Aug;108(2):269-75; discussion 275-6
    1. Gastroenterology. 1990 Oct;99(4):918-22
    1. Ann Surg. 1990 Oct;212(4):528-40; discussion 540-2
    1. Am J Surg. 1991 Jan;161(1):97-9; discussion 99-100
    1. Ann Surg. 1991 Feb;213(2):122-5
    1. JAMA. 1991 Mar 13;265(10):1287-9
    1. Gastroenterology. 1991 May;100(5 Pt 1):1266-78
    1. J Thorac Cardiovasc Surg. 1991 Jul;102(1):36-41; discussion 41-2
    1. Gastroenterology. 1991 Sep;101(3):618-25
    1. Gut. 1992 May;33(5):587-91
    1. Cancer. 1992 Aug 1;70(3):569-74
    1. Surg Gynecol Obstet. 1992 Aug;175(2):167-72
    1. Ann Thorac Surg. 1992 Sep;54(3):586-91
    1. Science. 1993 May 7;260(5109):812-6
    1. Gastroenterology. 1993 Jul;105(1):40-50
    1. Gastroenterology. 1993 Sep;105(3):837-44
    1. Ann Thorac Surg. 1993 Nov;56(5):1191-7
    1. Gastroenterology. 1994 Jun;106(6):1589-95
    1. Arch Surg. 1994 Jun;129(6):609-14
    1. Cancer. 1994 Aug 15;74(4):1225-9
    1. Gut. 1994 Oct;35(10):1348-51
    1. Am J Clin Pathol. 1978 Jul;70(1):1-5
    1. Cancer. 1982 Aug 15;50(4):775-81
    1. Hum Pathol. 1983 Jan;14(1):42-61
    1. J Cell Biol. 1985 Sep;101(3):838-51

Source: PubMed

3
Abonnieren